Clinical Scorecard: CLEAR Report 1: A Comprehensive Review and Meta-Analysis of Definitions, Imaging Metrics, and Functional Associations of Photoreceptor Integrity in Age-Related Macular Degeneration

At a Glance

Key Highlights

• OCT enables non-invasive quantification of photoreceptor integrity.
• High reliability for EZ and ONL metrics when definitions and methods are consistent.
• Moderate-to-strong correlations exist between photoreceptor loss and visual function.
• Substantial heterogeneity in definitions and reporting complicates cross-study comparisons.
• Consensus on boundary definitions and reporting standards is necessary for reproducibility.

Guideline-Based Recommendations

Diagnosis

• Utilize OCT-derived photoreceptor biomarkers for assessing AMD.

Management

• Adopt standardized definitions and reporting practices for photoreceptor metrics.

Monitoring & Follow-up

• Implement structure-function analyses to track disease progression.

Risks

• Inconsistent definitions may lead to misinterpretation of disease activity and treatment efficacy.

Patient & Prescribing Data

Patients with advanced AMD, including geographic atrophy and neovascular AMD.

Early intervention may be facilitated by identifying photoreceptor loss before complete atrophy.

Clinical Best Practices

• Ensure clear definitions and consistent application of measurement protocols in clinical studies.
• Utilize automated and deep learning methods for reproducible quantification in multicenter trials.
• Incorporate structure-function correlations in clinical assessments of AMD.

Related Resources & Content

• CLEAR initiative